Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone vs Ondansetron for PONV Prevention After Cesarean Delivery
NCT05692245Phase 4Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Mar 2023
- Primary completion
- Apr 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of dexamethasone, ondansetron in postoperative nausea and vomiting (PONV), sponsored by Beth Israel Deaconess Medical Center. Started Mar 2023; status: completed.
02
Drugs
dexamethasoneondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT05692245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05692245.